The approval was based on an open-label, multiple dose, multicenter, dose-finding study in 64 pediatric patients with CKD who were on hemodialysis and who had stable hemoglobin levels while previously ...

Austrian researchers have successfully developed a new electrophoretic method for detecting MIRCERA® and other erythropoietins (EPO) in the blood. The technique, using SARCOSYL-PAGE, has specifically ...

Human therapeutics company Amgen has succeeded in preventing rival Roche from launching its anaemia drug Mircera in the US, after a jury in the US Federal District Court in Boston found that the drug ...

BOSTON U.S. District Judge William Young has ordered Amgen and Roche to submit a list of names for an expert to be appointed to their trial regarding the release of Roche’s anemia drug, Mircera, in ...